Opportunities and Challenges for the Nasal Administration of Nanoemulsions
The DOI matches its Crossref record; 81 of the 81 references it cites were found in a registry or an index.
Abstract
Nasal delivery has become a growing area of interest for drug administration as a consequence of several practical advantages, such as ease of administration and non-invasiveness. Moreover, the avoidance of hepatic first-pass metabolism and rapid and efficient absorption across the permeable nasal mucosa offer a promising alternative to other traditional administration routes, such as oral or parenteral delivery. In fact, nasal delivery has been proposed for a number of applications, including local, systemic, direct nose-to-brain and mucosal vaccine delivery. Nanoemulsions, due to their stability, small droplet size and optimal solubilization properties, represent a versatile formulation approach suitable for several administration routes. Nanoemulsions demonstrated great potential in nasal drug delivery, increasing the absorption and the bioavailability of many drugs for systemic and nose-to-brain delivery. Furthermore, they act as an active component, i.e. an adjuvant, in nasal mucosal vaccinations, displaying the ability to induce robust mucosal immunity, high serum antibodies titres and a cellular immune response avoiding inflammatory response. Interestingly, nanoemulsions have not been proposed for the treatment of local ailments of the nose. Despite the promising results in vitro and in vitro, the application of nanoemulsions for nasal delivery in humans appears mainly hindered by the lack of detailed toxicology studies to determine the effect of these formulations on the nasal mucosa and cilia and the lack of extensive clinical trials.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“They consist of emulsions (commonly oil in water) stabilized by one or more surfactants—and eventually co-surfactants—delivered in droplets of small dimensions (sizes of 100–300 nm or less) with a high surface area.”
From Nanoemulsions for “Nose-to-Brain” Drug Delivery (2019) · cites this paper as [24]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“NEs can be used to solve problems of drug solubility and/or of drug stability (oxidation, pH, hydrolysis and enzymatic degradation at the mucosal level, under physiological conditions) [24,28].”
From Nanoemulsions for “Nose-to-Brain” Drug Delivery (2019) · cites this paper as [24]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Nanoemulsions (NEs) are oil-in-water (O/W) or water-in-oil (W/O) dispersions of two immiscible liquids stabilized using appropriate surfactant(s) [24], with a mean droplet diameter of about 100 nm [25], even if in literature upper size limits up to 300 nm [26] have been reported.”
From Nanoemulsions for “Nose-to-Brain” Drug Delivery (2019) · cites this paper as [24]
The cited source says what the claim attributes to it.
In the citing paper
“In the present literature there is some confusion regarding the classification of NEs because they are sometimes confused with microemulsions, which are thermodynamically stable systems that form spontaneously [24,46].”
From Nanoemulsions for “Nose-to-Brain” Drug Delivery (2019) · cites this paper as [24]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nanoemulsions versus microemulsions: terminology, differences, and similarities
McClements, D. J. (2012) · Soft Matter · doi:10.1039/c2sm06903b · Cited by 1,778
Intranasal delivery to the central nervous system: Mechanisms and experimental considerations
Dhuria, S. V., Hanson, L. R., & Frey, W. H. (2010) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.21924 · Cited by 1,239
Design and production of nanoparticles formulated from nano-emulsion templates-A review
Anton, N., Benoit, J.-P., & Saulnier, P. (2008) · Journal of Controlled Release · doi:10.1016/j.jconrel.2008.02.007 · Cited by 1,226
Mucosal vaccines: the promise and the challenge
Neutra, M. R., & Kozlowski, P. A. (2006) · Nature Reviews Immunology · doi:10.1038/nri1777 · Cited by 1,223
Transport of drugs from the nasal cavity to the central nervous system
Illum, L. (2000) · European Journal of Pharmaceutical Sciences · doi:10.1016/s0928-0987(00)00087-7 · Cited by 907
Recent progress in mucosal vaccine development: potential and limitations
Lycke, N. (2012) · Nature Reviews Immunology · doi:10.1038/nri3251 · Cited by 807
Nanoparticles for direct nose-to-brain delivery of drugs
Mistry, A., Stolnik, S., & Illum, L. (2009) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2009.06.019 · Cited by 734
Nano-emulsions: Formation by low-energy methods
Solans, C., & Solé, I. (2012) · Current Opinion in Colloid & Interface Science · doi:10.1016/j.cocis.2012.07.003 · Cited by 698
Intranasal Drug Delivery: How, Why and What For?
Pires, A., Fortuna, A., Alves, G., & Falcão, A. (2009) · Journal of Pharmacy & Pharmaceutical Sciences · doi:10.18433/j3nc79 · Cited by 641
Nano-emulsions and Micro-emulsions: Clarifications of the Critical Differences
Anton, N., & Vandamme, T. F. (2011) · Pharmaceutical Research · doi:10.1007/s11095-010-0309-1 · Cited by 621
Research works printed but not linked: 21
- [3][3] Sarkar, M. A. Drug metabolism in the nasal mucosa. Pharm. Res., 1992 , 9 (1), 1-9. -
- [4][4] Pardeshi, C. V.; Belgamwar, V. S. Direct nose to brain drug delivery via integrated nerve pathways bypassing the blood-brain barrier: an excellent platform for brain targeting. Expert Opin. Drug Deliv., 2013 , 10 (7), 957-972. -
- [10][10] Grassin-Delyle, S.; Buenestado, A.; Naline, E.; Faisy, C.; Blouquit-Laye, S.; Couderc, L.; Le Guen, M.; Fischler, M.; Devillier, P. Intranasal drug delivery: an efficient and non-invasive route for systemic administration: focus on opioids. Pharmacol. Ther., 2012 , 134 (3), 366-379. -
- [16][16] Solans, C.; Izquierdo, P.; Nolla, J.; Azemar, N.; Garcia-Celma, M. J. Nano-emulsions. Curr. Opin. Colloid Interface Sci., 2005 , 10 (3-4), 102-110. -
- [30][30] Brooks, B.W.; Richmond, H. Dynamics of liquid-liquid inversion using non-ionic surfactants. Colloids Surf. , 1991 , 58 (1-2), 131-148. -
- [32][32] Becher, S.E.; Schick, M.J. Macroemulsions. In: Surfactant Science Series, Nonionic Surfactants - Physical Chemistry . Schick, M.J., Ed.; Marcel Dekker: New York: Marcel Dekker Inc. (Ed.), 1987 . Vol. 23, pp. 435-491.
- [33][33] Sajjadi, S.; Jahanzad, F.;, Brooks, B.W. Phase inversion in abnormal O/W/O emulsions: effect of surfactant - concentration. Ind. Eng. Chem. Res. , 2002 , 41 , 6033-6041. 567 -
- [34][34] Shinoda, K.; Friberg, S.E. Factors affecting the phase inversion temperature in an emulsion. In: Emulsions 568 2. and solubilization ; Shinoda, K.; Friberg, S.E., Eds.; Wiley-Interscience: New York, 1986 , pp. 96-123. 569 -
- [38][38] Salager, J.L.; Forgiarini, A.; Marquéz, L.; Peña, A.; Pizzino, A.; Rodriguez, M.P.; González, M.R. Using 577 emulsion inversion in industrial process. Adv. Colloid Interface Sci. , 2004 , 259 , 108-109. 578 579 580 -
- [40][40] Kunieda, H.; Fukui, Y.; Uchiyama, H.; Solans, C. Spontaneous formation of highly concentrated water-inoil emulsions (gel-emulsions). Langmuir , 1996 , 12 (9), 2136-2140. -
- [43][43] Thakur, N.; Garg, G.; Sharma, P. K.; Kumar, N. Nanoemulsions: a review on various pharmaceutical applications. Global J. Pharmacol., 2012 , 6 (3), 222-225. -
- [48][48] Patel, R. P.; Joshi, J. R. An overview on nanoemulsion: A novel approach. Int. J. Pharm. Sci. Res., 2012 , 3 (12), 4640-4650. -
- [59][59] Mahajan, H. S.; Dinger, S. B. Design and in vitro evaluation of nanoemulsion for nasal delivery of artemether. Indian J. Novel Drug Deliv., 2011 , 3 (4), 272-277. -
- [60][60] Hosny, K. M.; Banjar, Z. M. The formulation of a nasal nanoemulsion zaleplon in situ gel for the treatment of insomnia. Expert Opin. Drug Deliv., 2013 , 10 (8), 1033-1041. -
- [63][63] Gugulothu, D.; Pathak, S.; Suryavanshi, S.; Sharma, S.; Patravale, V. Self-microemulsifiyng suppository formulation of β-artemether. AAPS PharmSciTech, 2010 , 11 (3), 1179-1184. -
- [70][70] Bielinska, A. U.; Makidon, P. E.; Janczak, K. W.; Blanco, L. P.; Swanson, B.; Smith, D. M.; Pham, T.; 652 Szabo, Z.; Kukowska-Latallo, J. F.; Baker, J. R.,Jr Distinct pathways of humoral and cellular immunity 653 induced with the mucosal administration of a nanoemulsion adjuvant. J. Immunol., 2014 , 192 (6), 2722654 2733. 655 -
- [71][71] Davis, S. Nasal vaccines. Adv. Drug Deliv. Rev., 2001 , 51 (1), 21-42. 656 -
- [80][80] Hamouda, T.; Sutcliffe, J. A.; Ciotti, S.; Baker, J. R.,Jr Intranasal immunization of ferrets with commercial 678 trivalent influenza vaccines formulated in a nanoemulsion-based adjuvant. Clin. Vaccine Immunol., 2011 , 679 18 (7), 1167-1175. 680 -
- [96][96] Samia, O.; Hanan, R.; Kamal, E. T. Carbamazepine Mucoadhesive Nanoemulgel (MNEG) as brain targeting delivery system via the olfactory mucosa. Drug Deliv., 2012 , 19 (1), 58-67. -
- [102][102] Jain, N.; Akhter, S.; Jain, G.K.; Khan, Z.I.; Khar, R.K.; Ahmad, F.J. Antiepileptic intranasal amiloride loaded mocoadhesive nanoemulsion: development and safety assessment. J. Biomed. Nanotechnol. , 2011 , 7 , 142-143. -
- [103][103] Davis, K.L.; Powchick, P. Tacrine. Lancet, 1995 , 345 (8950), 625-630.
Cited by
Surface-Modified Nanocarriers for Nose-To-Brain Delivery: From Bioadhesion to Targeting
Sonvico, F., Clementino, A. R., Buttini, F., Colombo, G., Pescina, S., Stanisçuaski Guterres, S., Raffin Pohlmann, A., & Nicoli, S. (2018) · doi:10.20944/preprints201802.0077.v1 · Cited by 306
“(a) Nasal innervation; (b) Nose-to-brain (N2B) pathways of drug delivery (modified from [15,16] with permission).”
BackgroundSelf-citationNanoemulsions for “Nose-to-Brain” Drug Delivery
Bonferoni, M. C., Rossi, S., Sandri, G., Ferrari, F., Gavini, E., Rassu, G., & Giunchedi, P. (2019) · Pharmaceutics · doi:10.3390/pharmaceutics11020084 · Cited by 269
Nanoemulsions in Drug Delivery: Formulation to Medical Application
Tayeb, H. H., & Sainsbury, F. (2018) · Nanomedicine · doi:10.2217/nnm-2018-0088 · Cited by 190
Colombo, M., Figueiró, F., de Fraga Dias, A., Teixeira, H. F., Battastini, A. M. O., & Koester, L. S. (2018) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2018.03.055 · Cited by 157
Chitosan-Coated Nanoparticles: Effect of Chitosan Molecular Weight on Nasal Transmucosal Delivery
Bruinsmann, F. A., Pigana, S., Aguirre, T. A. S., Souto, G. D., Pereira, G. G., Bianchera, A., Fasiolo, L. T., Colombo, G., Marques, M. D. S., Pohlmann, A. R., et al. (2019) · Pharmaceutics · doi:10.3390/pharmaceutics11020086 · Cited by 147
Self-citation
Metadata
- Authors
- Comfort, C., Garrastazu, G., Pozzoli, M., & Sonvico, F.
- Affiliations
- University of Technology Sydney (AU)
- Venue
- Current Topics in Medicinal Chemistry
- Publisher
- Bentham Science Publishers Ltd.
- Published
- 2015-02-10
- Volume
- 15
- Issue
- 4
- Pages
- 356-368
- ISSN
- 1568-0266 (ISSN-L)
- OpenAlex
- W2115015610
- Cited by
- 69
- References
- 81
- Citations by year
- 2026: 2 · 2025: 6 · 2024: 8 · 2023: 7 · 2022: 9 · 2021: 11 · 2020: 6 · 2019: 11 · 2018: 5 · 2017: 2 · 2016: 2
- FWCI
- 1.66
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Current Topics in Medicinal Chemistry (publishedVersion)
- PubMed (publishedVersion)
- UTS ePRESS (University of Technology Sydney) (submittedVersion)
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Advanced Drug Delivery Systems
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Inhalation and Respiratory Drug Delivery
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Advancements in Transdermal Drug Delivery
- Keywords
- intranasal drug delivery, nanoemulsions, nose-to-brain delivery, mucosal adjuvant, nasal mucosa, bioavailability, first-pass metabolism, cilia
- MeSH terms
- Administration, Intranasal, Emulsions, Humans, Nasal Mucosa, Nanostructures
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Opportunities and Challenges for the Nasal Administration of Nanoemulsions. https://app.cochat.ai/papers/10.2174/1568026615666150108144655
- The paper
- Comfort, C., Garrastazu, G., Pozzoli, M., & Sonvico, F. (2015). Opportunities and Challenges for the Nasal Administration of Nanoemulsions. Current Topics in Medicinal Chemistry. https://doi.org/10.2174/1568026615666150108144655
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.